Monomethyl Histone H4 Inhibitors

The category of Monomethyl Histone H4 Inhibitors encompasses a variety of chemicals designed to modulate the state of histone H4 monomethylation. These molecules target different aspects of the epigenetic machinery involved in installing, maintaining, or reading this particular modification. Key members such as BIX-01294 and UNC0638 exert their effect by inhibiting G9a and GLP methyltransferases, enzymes directly responsible for mediating monomethylation on histone H4. Others, like JIB-04, take an opposite route, inhibiting the removal of the methyl mark by targeting Jumonji histone demethylases.

Additionally, some inhibitors like MM-102 and EED226 work by disrupting the protein-protein interactions essential for the recruitment of methyltransferases to chromatin. MM-102 targets WDR5, which is crucial for the binding of methyltransferases, thereby decreasing their activity. EED226 interferes with the Polycomb Repressive Complex 2 (PRC2), which also participates in histone modifications including monomethylation. The inhibitors in this class are mechanistically diverse but are unified in their capability to influence the status of Histone H4 monomethylation. Their utility in modulating this epigenetic mark positions them as valuable tools for dissecting the functional implications of Histone H4 monomethylation in cellular processes.